(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the 2023 Medicare Part D proposed rule from the Centers for Medicare & Medicaid Services (CMS): “We are currently reviewing the proposed rule.
Court Ruling Finds that ERISA Preempts State PBM Law COURT REJECTS BID TO PREEMPT ERISA…In a unanimous decision, the U.S. Court of Appeals for the Tenth Circuit in PCMA v. Mulready court sustained PCMA’s challenge to four provisions in
New Milliman Analysis Shows Medicare Part D Proposed Rule Could Increase Premiums More than It Saves in Cost Sharing for Majority of Beneficiaries
Recent small fluctuations year-to-year in the number of independent pharmacies has not dramatically shifted the independent pharmacy market and continues to foster a stable market.
During the COVID-19 pandemic, the net number of retail independent pharmacies nationwide increased. The recent increases in the number of stores continued overall five- and ten-year trends of an increasing number of independent pharmacies in the United States. Use the interactive map below to show data for each state.
High Priced Drugs America’s PBMs are the only member of the prescription drug supply and payment chain working to reduce high drug costs, improve patient access, and increase affordability. PBMs administer prescription drug plans for more than 266 million Americans
©2024 PCMA. All Rights Reserved.
